About the Authors
- Barbara Dhooghe
-
Affiliation Louvain centre for Toxicology and Applied Pharmacology (LTAP), Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain, Brussels, Belgium
- Sabrina Noël
-
Affiliation Louvain centre for Toxicology and Applied Pharmacology (LTAP), Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain, Brussels, Belgium
- Caroline Bouzin
-
Affiliation IREC Imaging Platform/Pole of Pharmacology and Therapeutics, Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain, Brussels, Belgium
- Gaëtane Behets-Wydemans
-
Affiliation IREC Imaging Platform/Pole of Pharmacology and Therapeutics, Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain, Brussels, Belgium
- Teresinha Leal
-
* E-mail: teresinha.leal@uclouvain.be
Affiliation Louvain centre for Toxicology and Applied Pharmacology (LTAP), Institute of Experimental and Clinical Research (IREC), Université catholique de Louvain, Brussels, Belgium
Competing Interests
Vardenafil was kindly provided by Bayer Pharma. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: BD SN TL. Performed the experiments: BD. Analyzed the data: BD SN CB TL. Contributed reagents/materials/analysis tools: CB. Wrote the paper: BD TL. Cell imaging data analyses: BD GBW CB.